Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials
Christopher L. Hallemeier(Mayo Clinic in Arizona), Christopher H. Crane(Memorial Sloan Kettering Cancer Center), David A. Bush(Loma Linda University), Gordon Okawara(The University of Texas MD Anderson Cancer Center), Jennifer Moughan(NRG Oncology), Tracey E. Schefter(University of Colorado Anschutz Medical Campus), Bruce D. Greenwald(University of Maryland, Baltimore), Joshua E. Meyer(Fox Chase Cancer Center), Jerry L. Barker(Texas Oncology), Shane Lloyd(University of Utah), Ritsuko Komaki(The University of Texas MD Anderson Cancer Center), Gregory M.M. Videtic(Cleveland Clinic), Adam Raben(Christiana Care Health System), Lindsay Puckett(Medical College of Wisconsin), Michael G. Haddock(Mayo Clinic in Arizona), Kenneth L. Zeitzer(Jefferson Einstein Philadelphia Hospital), Carla I. Falkson, Arnold Herskovic(Rush University Medical Center), Bruce D. Minsky(The University of Texas MD Anderson Cancer Center), Hyun Kim(Washington University in St. Louis), Kathryn Winter(RTOG Foundation), Thomas E. Lad(John H. Stroger, Jr. Hospital of Cook County), Madhur Garg(Albert Einstein College of Medicine), Rojymon Jacob(University of Alabama at Birmingham), Mohan Suntharalingam(University of Maryland, Baltimore), Harold E. Kim(Wayne State University)
Cited by 17
Related Papers
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials
|Journal of Clinical Oncology|2011|609
Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline
|Journal of Clinical Oncology|2005|565